Top drugmakers brush off pharma tariffs, saying they have robust U.S. footprint
PositiveU.S News

Global drugmakers are responding positively to President Trump's announcement of 100% tariffs on imported pharmaceuticals, indicating that their significant investments in U.S. operations will help them manage the new taxes. This resilience showcases the strength of the pharmaceutical sector in the U.S. and highlights the ongoing commitment of these companies to the American market, which is crucial for both the economy and healthcare innovation.
— Curated by the World Pulse Now AI Editorial System